Immune responses to Japanese encephalitis virus

Current Topics in Microbiology and Immunology

Volumn 267, Issue , 2002, Pages 91-103

  Kurane, I ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INACTIVATED VIRUS VACCINE; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; VIRUS PROTEIN;

CELLULAR IMMUNITY; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; EPIDEMIC ENCEPHALITIS; FLAVIVIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION PREVENTION; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; STRAIN DIFFERENCE; T LYMPHOCYTE; TREATMENT OUTCOME; VACCINATION; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS STRAIN;

FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS;

EID: 0036113849     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-59403-8_5     Document Type: Review

References (48)

1. Establishment and characterization of Japanese encephalitis virus-specific, human CD4+ T cell clones: Flavivirus cross-reactivity, protein recognition and cytotoxic activity
2. Japanese encephalitis virus neutralizing antibodies among vaccinated residents in Miyagi prefecture: Beijing-1 strain vaccine
3. Characterization of two Japanese encephalitis virus strains isolated in Thailand
4. Antigenic and genetic variations among Japanese encephalitis virus strains belonging to genotype 1
5. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: A comparative study with conventional viral vaccine
6. The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: A one-year follow-up study in Thailand
7. Antibody-dependent enhancement of yellow fever and Japanese encephalitis virus neurovirulence
8. Two way cross-protection between West Nile and Japanese encephalitis virus in bonnet macaques
9. Immunity of Hamsterts to West Nile and Murray Valley viruses following immunization with St. Louis and Japanese B
10. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies
11. Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus
12. Encephalitis viruses belonging to the Families Flaviviridae, Togaviridae, and Bunyaviridae
13. Protection against Japanese encephalitis by inactivated vaccines
14. A completed field trial for an evaluation of the effectiveness of mouse-brain Japanese encephalitis vaccine
15. Japanese encephalitis: Immunocytochemical studies of viral antigen and inflammatory cells in fatal cases
16. Neutralizing antibody responses to Japanese encephalitis vaccine in children
17. A field trial with an improved Japanese encephalitis vaccine in nonendemic area of the disease
18. Monoclonal antibodies for dengue virus preM glycoprotein protect mice against lethal dengue infection
19. Protection of mice against Japanese encephalitis virus by passive administration of monoclonal antibodies
20. Antigenic comparison of envelope protein E between Japanese encephalitis and some other flavivirus using monoclonal antibodies
21. Japanese encephalitis vaccine
22. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus
23. Proliferative responses of human peripheral blood T lymphocytes against Japanese encephalitis antigens
24. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice
25. Induction of Japanese encephalitis virus-specific cytotoxic T lymphocytes in humans by Poxvirus-based JE vaccine candidates
26. Induction of Protective Immunity against Japanese encephalitis in mice by immunization with a plasmid encoding JE virus premembrane and envelope genes
27. Anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes
28. Homologous and heterologous neutralization antibody responses after immunization with Japanese encephalitis vaccine among Taiwan children
29. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice
30. The ecology of Japanese encephalitis virus in the Australian region
31. Molecular characterization of a neutralizing domain of Japanese encephalitis virus structural glycoproteins
32. Current status of Japanese encephalitis in Japan
33. A new observation on Japanese encephalitis vaccine
34. Flaviviruses
35. Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adaptively transferred virus-specific cytotoxic T lymphocytes: Requirement for L3T4 cells
36. A field study on Nakayama and Beijing strains of Japanese encephalitis vaccines
37. Immunity and protection of epidemic in Japanese encephalitis
38. Japanese encephalitis vaccine
39. Japanese encephalitis
40. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution
41. Flaviviridae: The viruses and their replication
42. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48
43. Neutralization antibody responses induced by Japanese encephalitis virus vaccine
44. Assessment of Neutralizing antibodies elicited by a vaccine (Nakayama) strain of Japanese encephalitis virus in Taiwan
45. Definition of an epitope on Japanese encephalitis virus (JEV) envelope protein recognized by JEV-specific murine CD8+ cytotoxic T lymphocytes
46. Investigation of maintenance of neutralizing antibody to Japanese encephalitis virus among senior high school students
47. The epidemiology of Japanese encephalitis: Prospects for prevention
48. Antigenic characterization of the live attenuated Japanese encephalitis vaccine virus SA14-14-12: A comparison with isolates of the virus covering a wide geographic area